Obrascón Huarte Lain (OHLA) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
13 Aug, 2026Executive summary
Achieved strong improvement in operating margins and profitability indicators in the first half of 2026, continuing positive trends from previous quarters and years.
Progressed on strategic objectives, reaffirming operational solidity and capacity for growth and value creation.
Resolved major historical contingencies, notably the Flaggers case and M-12 motorway litigation, reducing uncertainty and strengthening business visibility.
Sales rose 3.5% year-over-year to €1,749.0M, with EBITDA up 14.3% to €96.1M and EBIT up 25.3% to €57.9M, reflecting improved margins and operational efficiency.
The Services business is classified as discontinued following a strategic divestment decision.
Financial highlights
EBITDA from ongoing activities (excluding Flaggers impact) reached EUR 116.9 million, up 39% year-over-year, with a margin of 6.7%.
Recurrent EBIT was EUR 78.7 million, up 77.3% year-over-year, with a margin of 4.5%.
Total sales, including services division, were EUR 2.035 billion, up 3.4% year-over-year.
Net borrowings reduced to €-343.3M from €-489.1M at year-end 2025.
Liquidity position at end of H1 2026 was EUR 711.3 million, up from EUR 613 million at Q1 end.
Outlook and guidance
Reiterated 2026 objectives and business plan commitments, confident in achieving targets.
Full-year 2026 forecasts maintained despite temporary litigation impacts.
Guidance for 2026 ratified; no forward guidance for 2027 or beyond provided.
Structural cost-saving plan continues to support margin improvement.
Cash impact from Flaggers litigation expected to be offset in 2H26 or early 2027.
Latest events from Obrascón Huarte Lain
- EBITDA jumped 67.4% and net profit turned positive, with strong order book growth.OHLA
Q1 2026 - Record debt reduction, EBITDA growth, and legal clarity set up a strong 2026 outlook.OHLA
Q4 2025 - EBITDA surged 30% to €113M as recapitalisation and cost controls offset lower sales.OHLA
Q3 2025 - EBITDA rose 46.3% to €84.1M, leverage fell, and legal risks were reduced in H1 2025.OHLA
Q2 2025 - EBITDA margin improved and leverage reduced, but net loss widened on recapitalization costs.OHLA
Q1 2025 - Revenue up 17.4% to €2.65bn, but net loss of €58.3m amid recapitalization and asset sales.OHLA
Q3 2024 - Sales up 21.8% to EUR 1.72B, but net loss and capital increase mark a shift to deleveraging.OHLA
H1 2024 - Sales up 16%, EBITDA up 11.3%, leverage down, and €150M recapitalization completed.OHLA
Q4 2024